A gene fusion involving MET [denoted MET(13)–MET(15) fusion] was identified in two LC patients (7.1%) and a gene fusion involving FGFR3 (FGFR3-TACC3) was identified in one LC patient (3.6%). The gene discussed is TACC3; the disease is laryngotracheoesophageal cleft.